Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a …

H Kelly, HA Weiss, Y Benavente, S de Sanjose… - The lancet HIV, 2018 - thelancet.com
Background The interactions between antiretroviral therapy (ART) and high-risk human
papillomavirus (HPV) and cervical lesions in women living with HIV are poorly understood …

Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective

S Finocchario-Kessler, C Wexler, M Maloba… - BMC women's …, 2016 - Springer
Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …

HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer

G Liu, M Sharma, N Tan, RV Barnabas - Aids, 2018 - journals.lww.com
Objective: HIV-positive women have higher human papillomavirus (HPV) prevalence and
cervical cancer incidence than HIV-negative women, partly because of HIV's modifying effect …

Incidence and progression of cervical lesions in women with HIV: a systematic global review

SA Denslow, AF Rositch, C Firnhaber… - … journal of STD & …, 2014 - journals.sagepub.com
Global data on cervical lesion incidence and progression in HIV-positive women are
essential for understanding the natural history of cervical neoplasia and informing screening …

The catastrophic HPV/HIV dual viral oncogenomics in concert with dysregulated alternative splicing in cervical cancer

R Marima, R Hull, G Lolas, KN Syrigos… - International Journal of …, 2021 - mdpi.com
Cervical cancer is a public health problem and has devastating effects in low-to-middle-
income countries (LTMICs) such as the sub-Saharan African (SSA) countries. Infection by …

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART

DH Adler, L Kakinami, T Modisenyane, N Tshabangu… - Aids, 2012 - journals.lww.com
Objective: To determine the impact of HAART on incidence, regression, and progression of
cytopathological abnormalities in HIV-infected women. Design: Prospective cohort. Methods …

A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers

IT Katz, B Nkala, J Dietrich, M Wallace, LG Bekker… - PloS one, 2013 - journals.plos.org
Background In South Africa, the prevalence of oncogenic Human Papillomavirus (HPV) may
be as high as 64%, and cervical cancer is the leading cause of cancer-related death among …

Efavirenz has the highest anti-proliferative effect of non-nucleoside reverse transcriptase inhibitors against pancreatic cancer cells

M Hecht, S Erber, T Harrer, H Klinker, T Roth… - PLoS …, 2015 - journals.plos.org
Background Cancer prevention and therapy in HIV-1-infected patients will play an important
role in future. The non-nucleoside reverse transcriptase inhibitors (NNRTI) Efavirenz and …

Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic …

S Menon, R Rossi, N Zdraveska, M Kariisa… - BMJ open, 2017 - bmjopen.bmj.com
Objectives In sub-Saharan Africa, substantial international funding along with evidence-
based clinical practice have resulted in an unparalleled scale-up of access to antiretroviral …

'Worse than HIV'or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia

HL White, C Mulambia, M Sinkala… - Social science & …, 2012 - Elsevier
Invasive cervical cancer is the second most common cancer among women worldwide, with
approximately 85% of the disease burden occurring in developing countries. To date, there …